
Burcon Increases Non-Brokered Private Placement of Convertible Debentures to $6.9 Million | BRCNF Stock News

I'm PortAI, I can summarize articles.
Burcon NutraScience Corporation has increased its non-brokered private placement of convertible debentures to $6.9 million due to strong investor demand. CEO Kip Underwood expressed optimism about the company's revenue target of over $10 million for 2026, supported by insider participation of at least $5 million. The placement is conditionally approved by the Toronto Stock Exchange, pending compliance with terms and shareholder approval. Burcon specializes in plant-based protein innovation and holds a significant patent portfolio in this sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

